Publications & Talks
Publications & Talks
Swati is both a seasoned author and an accomplished scientific speaker, with more than 20 peer-reviewed publications across neurodegenerative diseases, neuroimmune mechanisms, next-generation sequencing, rare diseases, ageing and stem-cell–based therapeutic approaches. Her invited talks span an equally broad range of topics—from disease-mechanism discovery and translational biomarkers to innovative therapeutic modalities and complex cellular and animal models.
Recognized for her exceptional writing and presentation skills, Swati has a distinctive ability to distill complex data into clear, compelling narratives strengthened by visual storytelling. Her speaking style consistently engages diverse audiences—setting the stage for high-level scientific discussion, fostering enthusiasm, and elevating the overall experience of any event. She is frequently noted for creating immediate connection and establishing a compelling tone for meaningful scientific dialogue.
Journal Articles
-
1. Glycoprotein Non-Metastatic Melanoma Protein B (GPNMB): A Translational Pharmacodynamic Biomarker for PIKfyve Inhibition with VRG50635. Clinical and Translational Science • 2026 | PDF
2. Cerulenin Partially Corrects the Disrupted Developmental Transcriptomic Signature in Huntington's Disease Striatal Medium Spiny Neurons. Stem Cells • 2025 | PDF
3. Central TYK2 inhibition identifies TYK2 as a key neuroimmune modulator. The Proceedings of the National Academy of Sciences (PNAS) • 2025 | PDF
4. Proteomic Analysis of Huntington’s Disease Medium Spiny Neurons Identifies Alterations in Lipid Droplets. Molecular & Cellular Proteomics • 2023 | PDF
5. Modulating FKBP51 and autophagy lowers Huntingtin levels. Autophagy • 2021 | PDF
6. FOXO3 targets are reprogrammed as Huntington’s disease neural cells and striatal neurons face senescence with p16INK4a increase. Aging Cell • 2020 | PDF
7. Insulin-like growth factor 2 (IGF2) protects against Huntington's disease through the extracellular disposal of protein aggregates. Acta Neuropathologica • 2020 | PDF
8. Characterization and application of fluidic properties of trinucleotide repeat sequences by wax-on-plastic microfluidics. Journal of Materials Chemistry B • 2020 | PDF9. Modeling polyglutamine expansion diseases with induced pluripotent stem cells. Neurotherapeutics • 2019 | PDF
10. Nuclear receptor Nr4a1 regulates striatal striosome development and dopamine D1 receptor signaling. eNeuro • 2019 | PDF
11. Novel probes for label-free detection of neurodegenerative GGGGCC repeats associated with amyotrophic lateral sclerosis. Analytical and Bioanalytical Chemistry • 2019 | PDF12. Altered expression of matrix metalloproteinases and their endogenous inhibitors in a human isogenic stem cell model of Huntington’s Disease. Frontiers in Neuroscience • 2018 | PDF
13. Research towards tau imaging. Journal of Alzheimer’s Disease • 2011 | PDF
14. Imaging as a strategy for premortem diagnosis and staging of tauopathies. Current Alzheimer Research • 2010 | PDF
15. Modulation and detection of tau aggregation with small-molecule ligands. Current Alzheimer Research • 2009 | PDF
-
16. Progranulin expression is upregulated after spinal contusion in mice. Acta Neuropathologica • 2020 | PDF
-
17. Macrophage polarization impacts tunneling nanotube formation and intercellular organelle trafficking. Nature Scientific Reports • 2019 | PDF
18. Lysosomal cross-correction by hematopoietic stem cell-derived macrophages via tunneling nanotubes. Stem Cells • 2015 | PDF
19. Treatment of inherited eye defects by systemic hematopoietic stem cell transplantation. Investigative Ophthalmology & Visual Science (IOVS) • 2015 | PDF
-
20. Systematic comparative analysis of strand-specific RNA-seq library preparation methods for low input samples. Nature Scientific Reports • 2022 | PDF
-
21. ZIP-Delivery System for Therapeutic Delivery to the Brain.
Invited Talks (Selected)
Frontiers in Neuroscience – Emerging Biology and Therapeutics. Opening Speaker, Organizer & Moderator. PBSS Symposium. 2025.
Characterization of the Macrophage Response in HSC-Mediated Tissue Repair in Cystinosis. American Society for Gene and Cell Therapy Meeting. 2015. – Award Winner.
Lysosomal Cross-Correction by HSC-Derived Macrophages via Tunneling Nanotubes. Postdoctoral Research Symposium, UC San Diego. 2014.
Mechanism of HSC-Mediated Tissue Repair in Cystinosis. American Society for Gene and Cell Therapy Meeting. 2013.
Progranulin Function in CNS Injury and Disease. The Ohio State University. 2009.
Recombinant DNA Technology. University of Pune, India. 2004. – Award Winner.
Scientific Posters
ZIP-Delivery System for Therapeutic Delivery to the Brain. American Society for Gene and Cell Therapy Meeting. 2025
Proteomic Analysis of Synaptosomes in a Huntington’s Disease Mouse Model. American Society of Mass Spectrometry Conference. 2024.
TYK2 Inhibition Suppresses Pathogenic Astrocytic Activation. New York Stem Cell Foundation Conference. 2023.
Small Molecule Inhibitor of PIKfyve Rescues Amyotrophic Lateral Sclerosis progression. ALS/MND International Symposium. 2020.
FOXO3 Opposes p16INK4a Expression in Huntington’s Disease Stem Cell Models. Bay Area Aging Meeting. 2019.
Altered FKBP Expression Levels in Huntington’s Disease. Bay Area Aging Meeting, 2019.
Altered MMP Expression in Human Huntington’s Disease Stem Cell Models. Gordon Research Conference. 2017.
Treatment of Inherited Eye Defects by Systemic Hematopoietic Stem Cell (HSC) Transplantation. Pediatric Faculty Research Symposium, UC San Diego. 2015.
Hematopoietic Stem Cell (HSC)-Mediated Tissue Repair in Cystinosis.
- Pediatric Faculty Research Symposium, UC San Diego. 2014.
- American Society for Gene and Cell Therapy Meeting. 2015. – Meritorius Abstract Award.Progranulin Expression in Response to Spinal Cord Injury. The Ohio State University. 2011. – Award Winner.
P2-179: Small Molecule Probes of Tau Fibrillization. Alzheimer’s Association International Conference, 2008.